Results: 21

Síntese de evidências para políticas de saúde: prevenindo as complicações da doença falciforme
Evidence health policy brief: preventing the complications of sickle cell disease

Essa síntese teve como objetivo levantar opções para prevenção de complicações da doença falciforme, e informar sobre avanços na implementação da política no país. Seguem as opções descritas na síntese que já fazem parte das recomendações do Ministério da Saúde: Promover a antibiotic...

The Effect of Hydroxyurea Therapy on Adverse Clinical Events and Haematological Indices in Paediatric Patients with Sickle Cell Anaemia

West Indian med. j; 68 (2), 2019
ABSTRACT Objective: The aim of this study was to determine the effect of hydroxyurea on adverse clinical events and haematological indices in paediatric patients with sickle cell anaemia. Method: This study compared the same cohort of patients before and after hydroxyurea therapy, monitoring the rate o...

Does BCR-ABL transcript type influence the prognosis of patients in chronic myelogenous leukemia chronic phase?

ABSTRACT Introduction and objective: In this study, we evaluated the influence of the transcript type on hematological and clinical parameters, as well as the event-free survival of 50 patients in the Chronic myeloid leukemia chronic phase. Methods: We reviewed the medical records of 55 patients with C...

Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease

Einstein (Säo Paulo); 17 (4), 2019
ABSTRACT Objective To evaluate the induction of DNA damage in peripheral blood mononuclear cells of patients with sickle cell disease, SS and SC genotypes, treated with hydroxyurea. Methods The study subjects were divided into two groups: one group of 22 patients with sickle cell disease, SS and SC g...

Clinical and hematological profile in a newborn cohort with hemoglobin SC

J. pediatr. (Rio J.); 94 (6), 2018
Abstract Objectives: Hemoglobin SC is the second most common variant of sickle-cell disease worldwide, after hemoglobin SS. The objectives of the study were to describe the clinical and laboratory characteristics of hemoglobin SC disease in children from a newborn screening program and treated at a bloo...

Sickle cell anemia in Brazil: personal, medical and endodontic patterns

Braz. oral res. (Online); 30 (1), 2016
Abstract Sickle cell anemia (SCA) is the most prevalent genetic disease worldwide. Recurrent vaso-occlusive infarcts predispose SCA patients to infections, which are the primary causes of morbidly and mortality. This study aimed to evaluate the relationship between SCA and endodontic diseases. Personal i...

Úlceras por hidroxiurea en paciente con policitemia vera
Ulcers to hydroxyurea in a patient with polycythemia vera

Rev. chil. dermatol; 32 (4), 2016
La hidroxiurea es un agente citostático que inhibe la síntesis de ADN. Se considera el tratamiento de primera línea para algunos trastornos mieloproliferativos, enfermedad de células falciformes, casos severos de psoriasis refractaria y como adyuvante en la terapia de VIH. Se ha informado de que algu...

Eritropoietina para doença falciforme

INTRODUÇÃO: Trata-se de solicitação da Coordenação Geral de Sangue e Hemoderivados (CGSH/Departamento de Atenção Hospitalar e de Urgência) para ampliação de uso do medicamento eritropoietina para o tratamento de anemia falciforme com ou sem crise (D57.0 e D57.1) e distúrbio falciforme heteroz...

Hidroxiureia para crianças com doença falciforme

A Doença Falciforme (DF) é uma das doenças hereditárias mais comuns no mundo. A causa da doença é uma mutação no gene que produz a hemoglobina A originando outra mutante denominada hemoglobina S, que é uma herança recessiva. A presença de apenas um gene para hemoglobina S, combinado com outro ...